“…Active contrast agents have thus been introduced to enhance image quality, , which can change their properties in response to external stimuli, such as heat, light, and magnetic field. − Magnetomotive OCT, for example, takes advantage of the dynamic responses of magnetic particles to magnetic fields for imaging contrast . The lateral displacement of magnetic particles or rotation of anisotropic magnetic nanostructures under applied magnetic fields induces stresses within the viscoelastic biological medium, creating locoregional scattering changes for imaging contrast. , Suppression of noncontrast agent background can be achieved by pixel subtraction between actively modulated OCT images. , The use of magnetic particles also enables multimodal imaging, such as magnetic resonance imaging (MRI) and magnetic particle imaging, and synergistic cancer treatment by magnetothermal therapy. − However, magnetomotive OCT is facing a few challenges during its development. First, the reversible lateral displacement and retrieval of magnetomotive signals are highly reliant on the restoring force of the elastic tissue so that its imaging performance is attenuated by the pathophysiological heterogeneity of tissues and interpatient variations of tissue elasticity. − Second, in most cases, magnetic nanoparticles need to be first labeled on cells or functionalized by biological molecules for strong particle–tissue interactions, considerably large displacement, and detectable optical changes under magnetic fields .…”